Trxade Group's - TRXD market analysis on 21st January 2021

Transaction Date	Recipient	Shares	Type	Price	Value
14th December 2020	Donald G. Fell	500	Open or private sale	$5.30	$2,650.00
14th December 2020	Prashant Patel	7,500	Open or private sale	$5.29	$39,702.75
14th December 2020	Michael L Peterson	1,800	Open or private sale	$5.26	$9,460.08
14th December 2020	Pamela Tenaerts	800	Open or private sale	$5.30	$4,240.00
14th July 2020	Prashant Patel	7,000	Open or private sale	$5.44	$38,080.00
13th July 2020	Prashant Patel	500	Open or private sale	$5.71	$2,855.00
12th June 2020	Surendra K Ajjarapu	201,613	Other acquisition or disposition	$0.00
14th April 2020	Michael L Peterson	8,987	Grant/award etc.	$6.12	$55,000.44
14th April 2020	Pamela Tenaerts	8,987	Grant/award etc.	$6.12	$55,000.44
14th April 2020	Prashant Patel	50,000	Grant/award etc.	$6.12	$306,000.00

Trxade Group

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.

Ticker: TRXD

Sector: Commercial Services

Industry: Miscellaneous Commercial Services

SEC Central Index Key (CIK): 1382574

Employees: 32

Exchange: US OTC

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis